SF 5290·MN·senate
Addition requirement for certain pharmaceutical marketing expenses
FailedFiled May 13, 2026
Sponsor: Klein
Latest Action
Introduction and first reading; Referred to
May 13, 2026
Summary
The bill requires that expenses a company deducts for consumer‑focused drug advertising be added back to its Minnesota taxable income. It applies to both corporate franchise and individual income taxes and takes effect for tax years starting after Dec. 31, 2026. The change aims to reduce the tax benefit of such marketing spending.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when SF 5290 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SF 5290 freeOr ask your AI assistant about SF 5290 directly:
Add to Claude, ChatGPT or Cursor